Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Summary of the prevalence of BRCA1 mutation in the study cohort

From: Contribution of BRCA1 germline mutation in patients with sporadic breast cancer

Gene Exon Number and location of chroms Prevalence percentage
BRCA1 13 5 3.33%
Truncated Mutation* 13 1 0.66%